As the demand for COVID vaccines decreases worldwide, Moderna is planning to release a RSV vaccine, pending U.S. approval.
Moderna headquarters in Cambridge, Massachusetts.Moderna’s first-quarter revenue was slashed nearly in half over the course ...
The drugmaker is optimistic about higher sales with new vaccines and a little help from AI in the coming years.
Moderna stock fell 2.32% on April 3 due to concerns over a patent infringement complaint from Arbutus Biopharma. Despite challenges in 2023, Moderna anticipates reasonable revenue in 2024, with a ...
The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed by Pfizer and Moderna which target newer variants of the SARS-CoV-2 virus, it was announced ...
Pfizer, Inc. on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, driving shares down 9% to a 10-year low. Moderna says its updated coronavirus ...
NYC VACCINE TRACKER: Where you can get the COVID-19 shot in New York City Trying to find a vaccine available to you? This searchable tool helps you find locations with available doses in New York ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window WASHINGTON -- The benefits of combination vaccines may seem ...
For the first time, adults 60 and older are eligible to receive a vaccine against ...
adults who will be aged 75 years and over by 30 June 2024 people in care homes for older adults individuals aged six months and over who are immunosuppressed Vaccines will be available at ...